Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostisch Therapeutisches Zentrum (DTZ) Berlin is a certified medical care center with a 20+ year history in diagnostics and therapy, specializing in radiology, nuclear medicine, and modern radiotherapy. In December 2024, DTZ became the first center worldwide to treat a patient with the Elekta Evo, an AI-powered adaptive CT-Linac for personalized radiation therapy. They also have an in-house radiochemistry facility for producing diagnostic radiopharmaceuticals and provide advanced multimodal imaging including PET/CT, PET/MR, SPECT/CT, and SPECT/MR for precise diagnosis and individualized treatment of malignant and benign diseases.[1][2][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostisch Therapeutisches Zentrum.